糖尿病合并中低危冠脉病变患者PCI术后远期预后分析
结果显示SS 23-32组重复血运重建率更高,但两组死亡和心梗无差异;年龄、COPD、CCr<60等为心原性死亡独立危险因素。
要点
- SS 23-32的糖尿病患者PCI术后5年重复血运重建风险增加。
- SS 23-32与全因死亡、心原性死亡及再发心梗无独立相关。
- CCr<60 ml/min是心原性死亡和再发心梗的共同独立危险因素。
核心结论
- 在糖尿病合并中低危冠脉病变患者中,SS 23-32增加5年重复血运重建风险。
- 患者临床特征与远期死亡和再发心梗相关,而血运重建程度与之无关。
研究设计与样本
- 前瞻性单中心观察性研究,连续纳入2013年1至12月阜外医院行PCI且SS≤32的糖尿病患者。
- 按SS分为SS≤22组3450例和SS 23-32组449例。
- 主要终点为5年心原性死亡和再发心肌梗死,次要终点为全因死亡和重复血运重建。
主要发现
- SS 23-32组重复血运重建发生率18.9%(85/449),高于SS≤22组的15.2%(524/3450),log-rank P=0.019。
- 两组全因死亡、心原性死亡和再发心肌梗死发生率差异无统计学意义(log-rank P均>0.05)。
- 年龄(HR=1.05,95%CI 1.02-1.08,P<0.001)、COPD(HR=3.12,95%CI 1.37-7.07,P=0.007)和CCr<60 ml/min(HR=3.67,95%CI 2.05-6.58,P<0.001)是5年心原性死亡的独立危险因素。
- 左心室射血分数(HR=0.94,95%CI 0.91-0.96,P<0.001)是5年心原性死亡的保护因素。
- 既往PCI(HR=2.04,95%CI 1.38-3.00,P<0.001)、入院血糖≥11.1 mmol/L(HR=2.49,95%CI 1.32-4.70,P=0.005)和CCr<60 ml/min(HR=1.85,95%CI 1.14-2.99,P=0.012)是5年再发心肌梗死的独立危险因素。
关键数值与推荐
- SS 23-32是5年重复血运重建的独立危险因素(HR=1.54,95%CI 1.09-2.16,P=0.014)。
- 残余SYNTAX评分与5年预后无关。
临床怎么用
- 对糖尿病合并中低危冠脉病变患者,SS 23-32者应加强随访和血运重建风险管理。
- 关注年龄、COPD、CCr<60 ml/min、既往PCI和入院高血糖等临床特征以评估远期风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the clinical features and long-term prognostic factors of diabetic patients with low or intermediate complexity coronary artery disease (CAD) post percutaneous coronary intervention (PCI). Methods: This was a prospective, single-centre observational study. Consecutive diabetic patients with SYNTAX score (SS)≤32 undergoing PCI between January and December 2013 in Fuwai hospital were included in this analysis. The patients were divided into two groups based on SS, namely SS≤22 group and SS 23-32 group. Multivariate Cox regression analysis was performed to identify independent factors related to poor 5-year prognosis. The primary outcomes were cardiac death and recurrent myocardial infarction, the secondary outcomes were all cause death and revascularization. Results: Of the 3 899 patients included in the study, 2 888 were men (74.1%); mean age was 59.4±9.8 years. There were 3 450 patients in the SS≤22 group and 449 patients in the SS 23-32 group. Compared with SS≤22 group, the incidence of revascularization was higher in SS 23-32 group (18.9% (85/449) vs. 15.2% (524/3450), log-rank P=0.019). There was no significant difference in all-cause death, cardiac death and recurrent myocardial infarction between the two groups (log-rank P>0.05). Multivariate Cox regression analysis showed that age (HR=1.05, 95%CI 1.02-1.08, P<0.001), chronic obstructive pulmonary disease (HR=3.12, 95%CI 1.37-7.07, P=0.007) and creatinine clearance rate (CCr)<60 ml/min (HR=3.67, 95%CI 2.05-6.58, P<0.001) were independent risk factors for 5-year cardiac death, while left ventricular ejection fraction (HR=0.94, 95%CI 0.91-0.96, P<0.001) was a protective factor. Previous PCI (HR=2.04, 95%CI 1.38-3.00, P<0.001), blood glucose level≥11.1 mmol/L on admission (HR=2.49, 95%CI 1.32-4.70, P=0.005) and CCr<60 ml/min (HR=1.85, 95%CI 1.14-2.99, P=0.012) were independent risk factors for 5-year recurrent myocardial infarction. The SS of 23-32 was independently associated with risk of revascularization (HR=1.54, 95%CI 1.09-2.16, P=0.014), after adjusting for residual SS. Residual SS was not a risk factor for 5-year prognosis. Conclusions: In diabetic patients with low-or intermediate complexity CAD, SS 23-32 is associated with increased risk of 5-year revascularization; the clinical characteristics of the patients are associated with the long-term mortality and recurrent myocardial infarction, but not related to revascularization. 目的: 探讨合并糖尿病、冠状动脉病变解剖中低危(SYNTAX评分≤32)的冠心病患者,经皮冠状动脉介入治疗(PCI)术后远期预后的影响因素。 方法: 本研究为前瞻性单中心观察性研究。连续纳入2013年1至12月在阜外医院行PCI且SYNTAX评分≤32、合并糖尿病的患者。根据患者SYNTAX评分水平分为SYNTAX评分≤22组和23≤SYNTAX评分≤32组。主要终点是5年心原性死亡、再发心肌梗死,次要终点包括5年全因死亡和重复血运重建。采用Cox比例风险回归模型分析PCI术后远期预后的影响因素。 结果: 共纳入3 899例糖尿病合并冠心病患者,年龄(59.4±9.8)岁,其中男性2 888例(74.1%)。SYNTAX评分≤22组3 450例,23≤SYNTAX评分≤32组449例。术后5年,与SYNTAX评分≤22组相比,23≤SYNTAX评分≤32组患者重复血运重建发生率更高[18.9%(85/449)比15.2%(524/3 450),log-rankP=0.019],两组全因死亡、心原性死亡和再发心肌梗死发生率差异无统计学意义(log-rank P均>0.05)。多因素Cox回归分析结果显示,年龄(HR=1.05,95%CI 1.02~1.08,P<0.001)、慢性阻塞性肺病(HR=3.12,95%CI 1.37~7.07,P=0.007)和血清肌酐清除率(CCr)<60 ml/min(HR=3.67,95%CI 2.05~6.58,P<0.001)是5年心原性死亡的独立危险因素;左心室射血分数(HR=0.94,95%CI 0.91~0.96,P<0.001)是其保护因素。既往PCI史(HR=2.04,95%CI 1.38~3.00,P<0.001)、入院血糖水平≥11.1 mmol/L(HR=2.49,95%CI 1.32~4.70,P=0.005)和CCr<60 ml/min(HR=1.85,95%CI 1.14~2.99,P=0.012)是5年再发心肌梗死的独立危险因素。23≤SYNTAX评分≤32(HR=1.54,95%CI 1.09~2.16,P=0.014)是PCI术后5年重复血运重建的独立危险因素,与全因死亡、心原性死亡或再发心肌梗死均无独立相关性。残余SYNTAX评分与远期预后无关。 结论: 在合并糖尿病且冠状动脉病变中低危的冠心病患者中,SYNTAX评分23~32增加5年重复血运重建风险;患者临床特征与远期死亡、再发心肌梗死等远期心血管事件相关,而血运重建程度与其无关。.
引用
- Chen Y, Zhu P, Xu JJ, et al. [Clinical features and long-term prognosis of diabetic patients with low or intermediate complexity coronary artery disease post percutaneous coronary intervention]. Zhonghua Xin Xue Guan Bing Za Zhi. 2023. PMID: 36789593. doi:10.3760/cma.j.cn112148-20220601-00432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。